OptumRx sets demands for drugmaker price reductions

(By Alia Paavola for Becker’s Hospital Review)

OptumRx, UnitedHealth Group’s pharmacy benefit manager unit, reportedly sent a letter to pharmaceutical companies in December outlining several demands drugmakers must meet if they decide to lower list prices, according to a Bernstein investor memo.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.